Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Nagraj Gururaj Huilgol"'
Publikováno v:
Journal of Radiation and Cancer Research, Vol 8, Iss 2, Pp 108-111 (2017)
Introduction: Head and neck cancer (HNC) has large worldwide prevalence and accounts for almost 5% among all types of cancers. Nimotuzumab is a humanized anti-epidermal growth factor receptor monoclonal antibody that has shown promising results in pa
Externí odkaz:
https://doaj.org/article/865e3770fde54355bcf5c64a7ee700ff
Autor:
Nagraj Gururaj Huilgol
Publikováno v:
Journal of Radiation and Cancer Research, Vol 11, Iss 1, Pp 1-2 (2020)
Externí odkaz:
https://doaj.org/article/3ad26ae35a5c48c49c6c4c07e1ea5d86
Autor:
Nagraj Gururaj Huilgol
Publikováno v:
Journal of Radiation and Cancer Research, Vol 10, Iss 1, Pp 77-78 (2019)
Hyperthermia is an important adjunct to radiation therapy and chemotherapy. Heat includes in cellular organelle, cell membrane and vasculature. The changes can't be measured and imaged using magnetic resonance imaging. Currently, MRI thermometry is a
Externí odkaz:
https://doaj.org/article/721fb4cde21b4006b3028cc7f20b578d
Autor:
Nagraj Gururaj Huilgol
Publikováno v:
Journal of Radiation and Cancer Research, Vol 10, Iss 4, Pp 186-186 (2019)
Externí odkaz:
https://doaj.org/article/81935461b0ac4211a23d651b8eedd197
Autor:
Nagraj Gururaj Huilgol
Publikováno v:
Journal of Radiation and Cancer Research, Vol 10, Iss 4, Pp 155-155 (2019)
Externí odkaz:
https://doaj.org/article/d4ba75288c6b4d6fae31db63849796a9
Autor:
Nagraj Gururaj Huilgol
Publikováno v:
Journal of Radiation and Cancer Research, Vol 9, Iss 4, Pp 131-131 (2018)
Externí odkaz:
https://doaj.org/article/2fb131c31fec44058f51f2f47168b46a